This webinar aims to explore the transformation of safety teams from reactive cost centers to proactive benefit drivers, emphasizing the importance of providing teams with the right tools & resources to gain actionable insights.
hts.
Watch the webinar on demand
向最优秀的人学习
Join us as our expert speakers share valuable insights and practical knowledge drawn from extensive industry experience.
Country Manager Spain & Head of Global Vigilance Division
Dr. Angel Navarro is the Country Manager of Spain of QbD Group and Head of Vigilance Division. Founder and CEO of Azierta for more than 12 years (Azierta part of QbD Group), his track record endorses him as a strategic leader in the international pharmaceutical sector.
Head Global Business Development Pharma
Dr. Antonio Borregón is the Global Business Development Pharma Head at QbD Group. He has extensive experience in the pharmaceutical field with high-responsibility positions at the international level.
Richard Habis, a PharmD graduate from Saint Joseph University of Beirut, is a **seasoned expert in biopharmaceutical consulting and market research.** With a keen focus on rare diseases and patient-centered care, his expertise extends to leveraging real-world data to drive patient outcomes and healthcare insights. Mr. Habis’s professional journey reflects a strong commitment to integrating patient perspectives in digital health solutions.
Keep watching
点播网络研讨会Manage the risk of nitrosamines in the pharmaceutical industry. Watch our webinar on demand and learn about regulation and risk analysis from experts.
立即观看
点播网络研讨会This webinar provides guidance on managing pharmacovigilance (PV) across Europe, focusing on balancing global consistency with country-specific requirements. Participants will learn to meet strict European timelines while working with lean teams and practical strategies to enhance oversight and execution.
立即观看
点播网络研讨会This webinar offers a foundational understanding of Extractables and Leachables (E&L), highlighting their impact on drug safety and stability, and current regulatory frameworks. It covers toxicological assessments and best practices in study design, supported by real-world examples to navigate the complex landscape surrounding E&L.
立即观看专家观点直达您的收件箱——选择您的兴趣。
绝无垃圾邮件。随时取消订阅。
